(The Translational Genomics Research Institute) In the largest study of the associations between smoking and cardiovascular disease on cognitive function, researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, found both impair the ability to learn and memorize; and that the effects of smoking are more pronounced among females, while males are more impaired by cardiovascular disease. The results appear today in the journal Scientific Reports.
Market HighlightsThe Global Brain Implants Market is expected to register a CAGR of 9.30% during the forecast period with a market value of USD 5261.08 Million till 2023.Brain implant is an electronic system that enables communication between the brain and electronic devices thus permitting brain activity to be modified, recorded, and used for operating external assistive devices such as a computer cursor or a robotic arm.The rising neurological disorders, increasing geriatric population requiring treatment for neurological disorders through brain implants, and technological advancements in the field of medicine are significant factors expected to enhance the market growth.However, stringent regulatory framework and high cost of these devices are likely to curtail the growth of the market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6742Segment AnalysisThe global brain implants market, by type, has been segmented into spinal cord stimulator, deep brain stimulator, and vagus nerve stimulator.Based on application, the brain implants market has been categorized as chronic pain, epilepsy, Parkinson's disease, depression, essential tremor, and Alzheimer's disease.By end user, the global brain implants market has been classified as hospitals & clinics and specialty centers.Regional AnalysisThe global brain implants market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas led the market and accounted for the largest share of the brain implants market in 2017 owing to the increasing prevalence of neurological diseases, aging population with neurological conditions, and rising expenditure for research & development by healthcare bodies and government.Europe held a healthy share in the global brain implants market and is the second-largest market leader after the Americas, owing to the increasing neurological disease, rising geriatric population suffering from neurological ailments, and growing healthcare expenditure.For instance, according to the Alzheimer’s Disease International, in France, around 1.2 million had Alzheimer’s disease in 2015 and is estimated to reach 2.3 million by 2050.Asia-Pacific is expected to have a sturdy growth rate during the forecast period owing to the huge patient pool afflicted with neurological diseases and government initiatives for healthcare reforms.
Vocal Biomarkers Market information: by type (frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch, others) by indications (psychiatric disorders (depression, Attention Deficit and Disruptive Behavior Disorders, others), neurological disorders (Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, others), Respiratory Disorders, Cardiovascular Disorders, traumatic brain injury (TBI), others), others) by end users (hospitals and clinics, academic and research, others) - Global Forecast till 2027Vocal Biomarkers Market HighlightsThe global vocal biomarkers market is expected to exhibit a strong 14.5% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR).Vocal biomarkers are used to diagnose a wide range of diseases, including psychiatric disorders, respiratory disorders, and cardiovascular disorders.The global vocal biomarkers market is expected to rise to a valuation of USD 2.5 billion by 2023, driven by the increasing demand for strong diagnosis techniques in psychiatry and neurodegenerative disease treatment.Competitive Analysis:Leading players in the global vocal biomarkers market include Cogito Corporation, IBM Corporation, Audio Profiling, Sonde Health, and Beyond Verbal.In July 2019, Winterlight Labs Inc. announced a collaboration with Alector to develop speech-based digital biomarkers for fronto-temporal dementia.Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/3933Segmentation:The global vocal biomarkers market is segmented on the basis of type, indications, end users, and region.Based on type, the market has been segmented as frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch and others.Based on the indications, the market has been segmented as psychiatric disorders (depression, attention deficit and disruptive behavior disorders, others), neurological disorders (Parkinson’s disease (PD), Alzheimer's disease, Huntington's disease, others), respiratory disorders, cardiovascular disorders, traumatic brain injury (TBI), and others.The share of psychiatric disorders in the vocal biomarkers market is likely to increase over the forecast period, as the role of vocal biomarkers is much more prominent in the diagnosis of psychiatric diseases than in the diagnosis of cardiovascular or respiratory diseases.Based on the end use, the market has been segmented into hospitals and clinics, academic and research, and others.Regional Analysis:North America is likely to dominate the global vocal biomarkers market over the forecast period due to the growing awareness about neurodegenerative diseases, psychotic diseases, and the important role played by vocal biomarkers in identifying these afflictions.Rapid development of the medical technology sector has led to a growing interest in vocal biomarkers in recent years, as the technology needed for recognizing biomarkers and diagnosing various diseases has become matured over the last few years.The growing geriatric demographic in North America is likely to be a major driver for the vocal biomarkers market in the region, as leading rates of neurodegenerative diseases are seen among the geriatric demographic.
(Institute of Physical Chemistry of the Polish Academy of Sciences) Alzheimer's disease (AD) is a form of progressive dementia interfering with daily living. It is caused by the decline in the number of brain cells resulting in the deterioration of our mental abilities. One of the main reasons for the worsening brain cells condition and even the brain shrinkage are molecules having a specific structure called β-amyloids. They are peptides that tend to agglomerate around the nerve cells, becoming toxic and damage them.
(University of Bath) * A new method has been developed to measure how fast amyloid fibrils grow.* The team fired a beam of neutrons at the growing fibrils then used a 'contrast matching' method that made most of each fibril invisible to neutrons, so they could analyse the signal from the growing end alone.* The method will help scientists better understand diseases associated with amyloid fibrils, such as Alzheimer's, Parkinson's and Type 2 diabetes.
The global digital genome market analysis by MRFR expected to witness tremendous growth during the forecast period.Other essential factors influencing the growth of the market are increasing geriatric population, need for efficient diagnosis and treatment, increasing number of drug discoveries, growing biotech sector, increasing research in the field of genomics and rise in funding related to digitalization.With the help of digital genome identifying genomic variants is easy.However, factors such as high costs of digital genome techniques, lack of knowledge about the digital genome, security issues and inaccurate results are some of the factors expected to hinder the market growth during the forecast period.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1125 Market Drivers and Restraints:The high prevalence of various genetic disorders has generated the emergence of advanced techniques to study the issues and find remedies to them.The digital genome technology provides overall genetic make-up of the disease which aids in making critical decisions regarding the treatment procedures.The high demand for simplified genetic information in order to shorten the time required for understanding the diseases and providing relevant treatments is majorly driving the growth of the global digital genome market.The rapidly increasing geriatric population, current developments in the biotech sector, increasing prevalence of Alzheimer's disease and increasing research in the field of genomics are some of the major factors that are fueling the growth of the global digital genome market.However, the high cost of digital genome technology, lack of knowledge regarding digital genome, security issues and inaccuracy of the results are likely to create hindrance in the expansion of the global digital genome market.Market Segmentation:The global digital genome market has been segmented on the basis of product, application and end-users.
It is important to consider CBD products to meet your wellness and health.With the best guide, you will understand more about the variety of CBD products, forms, CBD strengths, and things to consider while choosing the right CBD product.Nowadays, people are using CBD Products to cure the treatments provided by a range of wide applications to support the relief of stress, pain, depression, and anxiety and reduce acute symptoms of different ailments that include Alzheimer's disease, diabetes, and cancer, among many.You will find that CBD potential is increasing much, and the laws in various countries are more lenient from some different studies.This is therefore helping the industry of cannabis to grow from one day to another.Fact about CBDCBD is a natural substance that is well-extracted from the cannabis plant.This will mean that the CBD intake is not causing the high effect.After deciding to use CBD products, you require to understand the best type that will meet your expectations.Types of CBD ProductToday's market has different CBD-infused products, from tinctures, syrups, and capsules to a certain one that includes face masks, vape pens, and protein powders.There will be some challenges with the different products and brands to determine your needs' good ones.
(Critical Path Institute (C-Path)) The Critical Path Institute's Critical Path for Alzheimer's Disease Consortium today announced that it is significantly expanding its Alzheimer's disease patient-level data repository with high-quality contemporary industry clinical trial datasets, focusing on early stages of the disease.
A common sleep disorder called sleep apnea may pave the way for dementia and Alzheimer’s disease later in life. Getting proper treatment for the condition, however, may help protect against the development of these tragic diseases, according to a new study from the Univerity of Michigan’s Michigan Medicine. That’s based on data from more than 50,000 people. Sleep apnea is … Continue reading
COVID-19 Impact Analysis on Neuron Tracing Software Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Neuron Tracing Software Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/neuron-tracing-software-market/download-sampleMarket DynamicsThe accurate reconstruction of neuron morphology, one of the most critical challenges in investigating how the brain works, and for quantitative analyses in neuroscience, will be the primary drivers for the market's growth.The increased investments in the area of research to understand learning, memory, and behavior systems in humans by accurate analysis of neuron morphology will benefit market growth.The rising cases of neurodevelopmental, neurodegenerative, and neurological disorders like dementia, Alzheimer's disease, Parkinson's disease, autism, and neuropathic pain will boost this software's demand.This market's main challenge is the lack of thorough knowledge about the brain's neural architecture, even among the medical community.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
(St John's College, University of Cambridge) Powerful algorithms used by Netflix, Amazon and Facebook can 'predict' the biological language of cancer and neurodegenerative diseases like Alzheimer's, scientists have found. Big data produced during decades of research was fed into a computer language model to see if artificial intelligence can make more advanced discoveries than humans.
(University of Minnesota) Head-mounted device on free-moving mice reveals how regions of the brain interact.
(KU Leuven) An interdisciplinary team led by KU Leuven and Stanford has identified 76 overlapping genetic locations that shape both our face and our brain. What the researchers didn't find is evidence that this genetic overlap also predicts someone's behavioural-cognitive traits or risk of conditions such as Alzheimer's disease. This means that the findings help to debunk several persistent pseudoscientific claims about what our face reveals about us.
The global radiopharmaceutical and therapeutics market should reach $22.0 billion by 2023 from $14.1 billion in 2018 at a compound annual growth rate (CAGR) of 9.2% for the period of 2018 to 2023.The technology market is divided into three types of radiation therapy, which are external beam radiation therapy, internal radiation therapy/brachytherapy and systemic radiation therapy.External radiotherapy by technology is divided into image-guided radiotherapy (IGRT), intensity modulated radiotherapy (IMRT), stereotactic technology, particle/proton beam therapy, tomotherapy, 3D-conformal radiotherapy (3D-CRT) and volumetric modulated ARC therapy.Internal radiotherapy by technology is divided into two types: low-dose brachytherapy and high-dose brachytherapy.The global radiation therapy market is segmented in this report by region: North America, Europe, Asia and the Rest of the World.Click Here to Get Sample Premium Report @ https://www.trendsmarketresearch.com/report/sample/12309Report Includes:- An overview of the global market for radiotherapy and related technologies and applications.- Analyses of market trends with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.- Discussion of major factors driving the growth for nuclear medicine, including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine.- Detailed information concerning major challenges the market faces, including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes.- Analyses of the diagnostic applications for radiotherapy, such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET).- Comprehensive company profiles of major players in the industry.Major players include Varian (U.S.), Elekta (Sweden), IBA-Worldwide Proton Therapy (Belgium) and Accuray (U.S.).Buy Now report with Analysis of COVID-19 @ https://www.trendsmarketresearch.com/checkout/12309/SingleSeveral major drivers are expected to boost the growth of this market in the forecasted period, including government funding through constant reimbursement continuous R applied to different applications; and the fact that radiation therapy is an efficient treatment.
(American Geriatrics Society) Insights into molecular changes in the brains of Alzheimer's patients, a new model for predicting the life expectancy of older adults with multiple chronic diseases and age-related vulnerability, and older adults' and healthcare professionals' perspectives on gun retirement are the subjects of top-line presentations at the American Geriatrics Society (AGS) 2021 Virtual Annual Scientific Meeting (#AGS21) (May 13-15, with pre-conference May 12).
Market Analysis and Insights: Global Dementia Treatment MarketDementia treatment market is expected to gain market growth in the forecast period of 2020 to 2027.In addition, vulnerable aging population can consider a positive measure for the growth of this market.Furthermore, government incentives and benefits through special designation can attributed to the growth of this market.Get More Insights About Global Dementia Treatment Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dementia-treatment-marketDementia is a syndrome characterized by the deterioration in the memory, cognitive skills and other imperative skills that affects the person’s ability to perform normal activities.It is a result of various CNS disorders such as Alzheimer's disease or stroke and certain injuries that affects the brain.Global dementia treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market.To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.Know more about this report https://www.databridgemarketresearch.com/reports/global-dementia-treatment-marketGlobal Dementia Treatment Market Scope and Market SizeGlobal dementia treatment market is segmented on the basis of types, drug class, therapy type, route of administration, end-users and distribution channel.On the basis of types, the dementia treatment market is segmented into alzheimer's disease dementia, vascular dementia, dementia with lewy bodies (DLB), parkinson's disease dementia, mixed dementia, frontotemporal dementia, others.The drug class segment for dementia treatment market includes MAO inhibitors, glutamate inhibitors, cholinesterase inhibitors and others.On the basis of therapy type, dementia treatment market is segmented into cognitive stimulation therapy, cognitive behavioral therapy (CBT)).On the basis of route of administration, dementia treatment market is segmented into oral and parenteral.On the basis of end-users, the dementia treatment market is segmented into hospitals, specialty clinics and others.On the basis of distribution channel, the dementia treatment market has also been segmented into hospitals, specialty clinics and others.Dementia Treatment Market Country Level AnalysisGlobal dementia treatment market is analyzed and market size information is provided by country, technology, type, indication, end-users and distribution channel as referenced above.The countries covered in the dementia treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.North America was the leading revenue contributor to the dementia treatment market due to increasing incidence of dementia and presence of key players in the same geography while Asia- Pacific is anticipated to maintained substantial growth because of the increasing awareness programs about dementia and availability of effective drugs in this particular region.The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market.
Market ScopeBrain implants market 2020 is set to advance at a robust rate of 9.30% between 2015 and 2023 (evaluation period), says Market Research Future (MRFR).We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6742Key Impacting Factors and ChallengesThe World Health Organization says that in 2017, close to 50 million people across world had epilepsy, while Alzheimer's Research UK claims that nearly 46.8 million people were affected by dementia in 2015.The latter is expected to touch 75 million cases by 2030 and by 2050, it will be 131.5 million.Alzheimer's disease International suggests that the overall cost of dementia was around USD 818 billion in 2015, indicating almost 1.09% of the total GDP.This cost can reach a whopping USD 1 trillion by 2018.All of these numbers signify the heavy burden of neurological conditions and disorders across countries and the escalating healthcare spending on dementia, which can foster the demand for brain implant devices in the following years.Players are actively involved in adopting marketing strategies such as alliances, product range diversification, bolstering distribution channels and new launches to expand their global reach.
(University of Colorado Anschutz Medical Campus) Children with Down syndrome are 20-times more likely to develop acute lymphocytic leukemia (ALL) and 150-times more likely to develop acute myeloid leukemia (AML) compared to their typical peers. According to a new study by researchers at the Linda Crnic Institute for Down Syndrome, the reason could be that children with Down syndrome are more likely to present with clonal hematopoiesis (CH), a process in which a blood stem cell acquires a genetic mutation that promotes replication.
(Centro Nacional de Investigaciones Oncológicas (CNIO)) * Researchers from the Proteomics Core Unit at CNIO have described molecular mechanisms, unknown to date, involved in the maintenance of the naïve state of the embryonic stem cells* The naïve state is optimal for the quest for treatments for heart disease or neurodegenerative disorders, but it is also the most unstable and difficult to maintain* The results of the study, published in 'Nature Communications', might prove useful to study some types of cancer
(Alzheimer's Research UK) The development of a wearable to detect early Alzheimer's and other neurodegenerative diseases years before symptoms show has taken a step closer to reality today, as UK charity Alzheimer's Research UK announces a partnership with Boston University that will see the first digital data flowing into its global Early Detection of Neurodegenerative diseases (EDoN) initiative.